Type 2 diabetes trials in Spain

In Spain 57 Also abroad 1200

46 of 57 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseEnrolling by invitation
SMARTCLOTH. Design, Implementation and Study of the Effectiveness and Usability of a Digital Tablecloth for Self-management of Diet in Diabetic Patients.
Where
Córdoba
Age
18 years to 70 years
People
90
Run by
Maimónides Biomedical Research Institute of Córdoba
See details and how to joinNCT06623708
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
A Coruna, Barcelona, Castilleja De La Cuesta, Madrid, Pamplona, Santander, Sevilla, Valencia
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
A Coruña, Badalona, Barcelona, Ferrol, Madrid, Málaga, Pozuelo de Alarcón, Sevilla
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
AMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Almería, Barcelona, Cabra, Castilleja De La Cuesta, Pozuelo de Alarcón, San Cugat del Vallés, Santa Cruz de Tenerife, Santander, Vic
Age
18 years and over
People
595 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525472-26-00 · EU 2026-525472-26-00
Phase 3Taking people
AMBITION 4: A research study investigating how well zenagamtide at lower dose levels lowers blood sugar and body weight compared to semaglutide at lower dose levels in people with type 2 diabetes treated with metformin, SGLT2i, or both
Where
Barcelona, Girona, L'Hospitalet de Llobregat (Barcelona), Monzón, Salamanca, Sevilla
Age
18 years and over
People
245 worldwide
Run by
Novo Nordisk A/S
See details and how to join2026-525474-20-00 · EU 2026-525474-20-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
A Coruna, Madrid, Pozuelo de Alarcón, Sevilla
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Where
Barcelona, Málaga, Sevilla
Age
10 years to 17 years
People
170 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Alzira, Barcelona, Castilleja De La Cuesta, Madrid, Málaga, Sevilla, Centro Médico Compostela
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
A Coruna, Almería, Barcelona, Castilleja De La Cuesta, Ferrol, Palma, Pozuelo de Alarcón, Santander, Sevilla
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
A Coruña, Alzira, Barcelona, Ferrol, Granada, Málaga, Seville
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in Spain
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
A Coruña, Alzira, Castilleja De La Cuesta, Ferrol, Granada, Lugo, Madrid, Majadahonda, Palma, Pozuelo de Alarcón, Santander, Sevilla, Valencia
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Badalona, Barcelona, Córdoba, Galdakao, Granada, Huelva, Jaén, Las Palmas De Gran Canaria, Madrid, Sabadell, Santander, Sevilla, Toledo, Valencia, Valladolid, Vigo, Villamartín
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
A Coruña, Alzira (Valencia), Barcelona, Castilleja de La Cuesta, Sevilla, Ferrol (A Coruña), Lleida, Málaga, Oviedo, Segovia, Seville
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
A Coruña, Almería, Badalona, Barcelona, León, Madrid, Santander, Santiago de Compostela, Seville, Tarragona, Valencia
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Taking people
A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
Where
A Coruña, Alzira, Barcelona, Castilleja De La Cuesta, Ferrol, Lleida, Málaga, Oviedo, Segovia, Sevilla
Age
18 years and over
People
420 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524616-11-00 · EU 2025-524616-11-00
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Where
Barcelona, Centelles, Madrid, Santander, Sevilla, Vic
Age
18 years to 75 years
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00
Phase 3Not yet taking people in Spain
Impact of Semaglutide in Liver Transplant Candidates with Obesity (SOMAL Study): A Prospective Randomized Study.
Where
Murcia
Age
18 years and over
People
50
Run by
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
See details and how to join2026-526953-32-00 · EU 2026-526953-32-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
A Coruña, Antequera, Barcelona, Centelles, Fuenlabrada, Girona, Madrid, Málaga, Manresa, Valladolid
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
No phaseTaking people
Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
Where
Valencia
Age
18 years to 83 years
People
120
Run by
Fundación para la Investigación del Hospital Clínico de Valencia
See details and how to joinNCT07828847
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Where
A Estrada, Barcelona, Castilleja De La Cuesta, Girona, Santiago de Compostela
Age
18 years to 75 years
People
270 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00
Phase 3Taking people
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Where
A Coruna, Almería, Badalona, Barcelona, Castilleja De La Cuesta, León, Madrid, Santander, Santiago de Compostela, Sevilla, Tarragona, Valencia
Age
18 years and over
People
1,010 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00
Phase 3Not yet taking people in Spain
Study of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
Where
Chiclana De La Frontera, Ferrol, Huelva, Madrid, Málaga, Salamanca, Santiago de Compostela, Sant Joan d'Alacant, Sevilla, Toledo, Valladolid
Age
18 years and over
People
760 worldwide
Run by
Tecnimede-Sociedade Tecnico-Medicinal S.A.
See details and how to join2025-524606-15-00 · EU 2025-524606-15-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Barcelona, Castilleja De La Cuesta, Ferrol, Lleida, Madrid, Majadahonda, Málaga, Santander, Sevilla, Valencia, Zaragoza
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
A Coruña, Barcelona, Móstoles, Sanlúcar de Barrameda, Santiago de Compostela, Segovia, Valencia
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Where
Barcelona, Figueres, Seville
Age
18 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00